ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.

ALRN Aileron Therapeutics Inc

3,24
-0,05 (-1,52%)
08 Juin 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Aileron Therapeutics Inc ALRN NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
-0,05 -1,52% 3,24 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
3,28 3,1001 3,30 3,24 3,29
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
05/6/202412:58EDGAR2Form 8-K - Current report
16/5/202423:19EDGAR2Form 3 - Initial statement of beneficial ownership of..
16/5/202423:01EDGAR2Form 8-K - Current report
15/5/202423:16EDGAR2Form 8-K - Current report
15/5/202423:13GLOBEAileron Therapeutics Reports First Quarter 2024 Financial..
15/5/202423:08EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/5/202422:05GLOBEAileron Therapeutics to Present at Two Upcoming Investor..
03/5/202422:05GLOBEAileron Therapeutics Announces Closing of Underwritten..
01/5/202414:45GLOBEAileron Therapeutics Announces Pricing of Underwritten..
01/5/202414:30GLOBEAileron Therapeutics Announces Positive Data from Cohort 1..
15/4/202423:20GLOBEAileron Therapeutics Reports Fourth Quarter and Full Year..
12/3/202413:00GLOBEAileron Therapeutics Announces CEO Transition
06/3/202423:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202413:01EDGAR2Form 8-K - Current report
15/2/202422:05GLOBEAileron Therapeutics and Pulmonary Care Experts To Discuss..
13/2/202413:01EDGAR2Form 8-K - Current report
06/2/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
05/2/202419:20EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
01/2/202422:30GLOBEAileron Therapeutics to Host Key Opinion Leader Event on..
31/1/202422:05EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
29/1/202422:15EDGAR2Form S-8 - Securities to be offered to employees in employee..
29/1/202422:10EDGAR2Form S-3 - Registration statement under Securities Act of..
29/1/202414:46EDGAR2Form DEF 14A - Other definitive proxy statements
29/1/202414:14EDGAR2Form 8-K - Current report
25/1/202413:00EDGAR2Form 8-K - Current report
19/1/202422:44EDGAR2Form PRE 14A - Other preliminary proxy statements
11/1/202422:18EDGAR2Form 8-K/A - Current report: [Amend]
10/1/202422:08EDGAR2Form 8-K - Current report
18/12/202323:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/11/202322:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202323:08EDGAR2Form SC 13G - Statement of acquisition of beneficial..
03/11/202301:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/11/202301:50EDGAR2Form 3 - Initial statement of beneficial ownership of..
03/11/202301:47EDGAR2Form 3 - Initial statement of beneficial ownership of..
31/10/202317:40EDGAR2Form 8-K - Current report
31/10/202317:30PRNUSAileron Therapeutics Announces Acquisition of Lung..
13/10/202322:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/8/202322:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]